| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Aortic Valve Stenosis | 18 | 2019 | 741 | 6.28 | Why? |
| Transcatheter Aortic Valve Replacement | 20 | 2019 | 839 | 6.15 | Why? |
| Percutaneous Coronary Intervention | 34 | 2020 | 3646 | 3.88 | Why? |
| Coronary Artery Disease | 27 | 2019 | 2570 | 3.34 | Why? |
| Absorbable Implants | 16 | 2019 | 191 | 3.23 | Why? |
| Aortic Valve | 10 | 2019 | 664 | 2.43 | Why? |
| Drug-Eluting Stents | 13 | 2019 | 562 | 2.15 | Why? |
| Poland | 30 | 2021 | 2368 | 2.02 | Why? |
| Coronary Vessels | 13 | 2019 | 914 | 1.96 | Why? |
| Cardiac Catheterization | 7 | 2018 | 882 | 1.88 | Why? |
| Cardiology | 15 | 2020 | 2873 | 1.69 | Why? |
| Acute Coronary Syndrome | 14 | 2021 | 2107 | 1.60 | Why? |
| Balloon Valvuloplasty | 3 | 2017 | 49 | 1.52 | Why? |
| Coronary Angiography | 22 | 2020 | 2275 | 1.42 | Why? |
| Cardiovascular Agents | 7 | 2018 | 663 | 1.28 | Why? |
| Nitroglycerin | 2 | 2017 | 39 | 1.26 | Why? |
| Myocardial Infarction | 12 | 2020 | 3361 | 1.21 | Why? |
| ST Elevation Myocardial Infarction | 9 | 2021 | 3051 | 1.18 | Why? |
| Everolimus | 6 | 2018 | 215 | 1.05 | Why? |
| Sirolimus | 5 | 2018 | 240 | 1.05 | Why? |
| Heart Valve Prosthesis | 4 | 2019 | 533 | 1.04 | Why? |
| Atherectomy, Coronary | 3 | 2018 | 35 | 1.01 | Why? |
| Coated Materials, Biocompatible | 3 | 2018 | 113 | 0.91 | Why? |
| Angioplasty, Balloon, Coronary | 9 | 2019 | 365 | 0.91 | Why? |
| Angina, Stable | 2 | 2018 | 45 | 0.90 | Why? |
| Registries | 19 | 2021 | 12327 | 0.86 | Why? |
| Postoperative Complications | 7 | 2019 | 5861 | 0.85 | Why? |
| Blood Flow Velocity | 2 | 2018 | 193 | 0.78 | Why? |
| Ultrasonography, Doppler, Duplex | 2 | 2018 | 168 | 0.77 | Why? |
| Receptors, Purinergic P2Y12 | 2 | 2018 | 42 | 0.77 | Why? |
| Purinergic P2Y Receptor Antagonists | 2 | 2018 | 206 | 0.76 | Why? |
| Neointima | 2 | 2017 | 39 | 0.75 | Why? |
| Psoas Muscles | 1 | 2018 | 28 | 0.73 | Why? |
| Coronary Stenosis | 6 | 2019 | 273 | 0.72 | Why? |
| Tomography, Optical Coherence | 5 | 2017 | 1008 | 0.70 | Why? |
| Heart Septal Defects, Atrial | 4 | 2019 | 61 | 0.70 | Why? |
| Vasomotor System | 1 | 2017 | 13 | 0.69 | Why? |
| Cardiovascular Surgical Procedures | 1 | 2021 | 281 | 0.68 | Why? |
| Cardiac Care Facilities | 1 | 2018 | 79 | 0.68 | Why? |
| Treatment Outcome | 44 | 2020 | 51732 | 0.67 | Why? |
| Vertebral Artery | 1 | 2017 | 52 | 0.66 | Why? |
| Tricuspid Valve | 1 | 2017 | 91 | 0.64 | Why? |
| Galectin 3 | 1 | 2017 | 76 | 0.64 | Why? |
| Aneurysm, False | 1 | 2017 | 88 | 0.63 | Why? |
| Intraoperative Care | 1 | 2018 | 238 | 0.62 | Why? |
| Tricuspid Valve Insufficiency | 1 | 2017 | 94 | 0.62 | Why? |
| Computer Security | 1 | 2020 | 408 | 0.61 | Why? |
| Frailty | 2 | 2018 | 1432 | 0.61 | Why? |
| Hand Strength | 1 | 2016 | 202 | 0.60 | Why? |
| Intraoperative Complications | 1 | 2018 | 221 | 0.60 | Why? |
| Carotid Arteries | 1 | 2017 | 182 | 0.58 | Why? |
| Hemodynamics | 3 | 2019 | 1562 | 0.58 | Why? |
| Coronary Vasospasm | 1 | 2015 | 36 | 0.58 | Why? |
| Reoperation | 1 | 2018 | 544 | 0.57 | Why? |
| Atrial Septum | 3 | 2018 | 9 | 0.56 | Why? |
| Vasodilation | 1 | 2017 | 258 | 0.56 | Why? |
| Risk Assessment | 13 | 2019 | 25439 | 0.55 | Why? |
| Hypotension | 1 | 2018 | 392 | 0.55 | Why? |
| Cardiac Surgical Procedures | 2 | 2018 | 1931 | 0.54 | Why? |
| Multidetector Computed Tomography | 4 | 2018 | 307 | 0.53 | Why? |
| Vasodilator Agents | 1 | 2017 | 344 | 0.53 | Why? |
| Catheterization, Peripheral | 1 | 2017 | 249 | 0.53 | Why? |
| Walk Test | 1 | 2016 | 461 | 0.53 | Why? |
| Tissue Scaffolds | 5 | 2019 | 174 | 0.50 | Why? |
| Heart Valve Prosthesis Implantation | 1 | 2019 | 552 | 0.50 | Why? |
| Aged, 80 and over | 32 | 2019 | 88759 | 0.48 | Why? |
| Virtual Reality | 1 | 2020 | 640 | 0.46 | Why? |
| Societies, Medical | 5 | 2019 | 6907 | 0.45 | Why? |
| Calcium Channel Blockers | 1 | 2015 | 367 | 0.45 | Why? |
| Coronary Restenosis | 4 | 2019 | 153 | 0.45 | Why? |
| Time Factors | 25 | 2020 | 31397 | 0.44 | Why? |
| Aged | 55 | 2021 | 215776 | 0.44 | Why? |
| Stents | 5 | 2019 | 916 | 0.43 | Why? |
| Exercise Test | 1 | 2017 | 911 | 0.41 | Why? |
| Risk Factors | 30 | 2019 | 71621 | 0.41 | Why? |
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2010 | 72 | 0.41 | Why? |
| Prosthesis Design | 9 | 2019 | 594 | 0.41 | Why? |
| Echocardiography, Transesophageal | 3 | 2018 | 447 | 0.41 | Why? |
| Pulmonary Disease, Chronic Obstructive | 5 | 2018 | 3832 | 0.39 | Why? |
| Heart-Assist Devices | 1 | 2018 | 812 | 0.39 | Why? |
| Male | 63 | 2020 | 367725 | 0.37 | Why? |
| Heart Arrest | 3 | 2018 | 1239 | 0.37 | Why? |
| Peptide Fragments | 2 | 2019 | 2075 | 0.36 | Why? |
| Platelet Aggregation Inhibitors | 6 | 2018 | 1671 | 0.36 | Why? |
| Diverticulum | 2 | 2018 | 28 | 0.35 | Why? |
| Hypersensitivity | 1 | 2018 | 1137 | 0.35 | Why? |
| Female | 62 | 2020 | 380317 | 0.35 | Why? |
| Hypertension, Pulmonary | 1 | 2017 | 970 | 0.35 | Why? |
| Metals | 3 | 2019 | 182 | 0.34 | Why? |
| Ultrasonography, Interventional | 7 | 2018 | 560 | 0.33 | Why? |
| Humans | 97 | 2021 | 930598 | 0.33 | Why? |
| Blood Transfusion | 1 | 2017 | 1399 | 0.33 | Why? |
| Delirium | 1 | 2017 | 1061 | 0.33 | Why? |
| Practice Patterns, Physicians' | 4 | 2020 | 4927 | 0.33 | Why? |
| Foramen Ovale, Patent | 2 | 2019 | 153 | 0.32 | Why? |
| Femoral Artery | 2 | 2019 | 213 | 0.31 | Why? |
| Peripheral Vascular Diseases | 1 | 2007 | 133 | 0.31 | Why? |
| Europe | 11 | 2020 | 12702 | 0.28 | Why? |
| Quality of Life | 4 | 2018 | 9820 | 0.27 | Why? |
| Psoriasis | 1 | 2018 | 1739 | 0.27 | Why? |
| Mitral Valve | 2 | 2017 | 342 | 0.26 | Why? |
| Stroke | 5 | 2018 | 8839 | 0.26 | Why? |
| Heart Diseases | 2 | 2020 | 3503 | 0.26 | Why? |
| Coronary Thrombosis | 4 | 2018 | 433 | 0.25 | Why? |
| Peripheral Arterial Disease | 2 | 2019 | 471 | 0.25 | Why? |
| Elective Surgical Procedures | 1 | 2021 | 5338 | 0.24 | Why? |
| Clinical Competence | 1 | 2018 | 3263 | 0.24 | Why? |
| Prospective Studies | 15 | 2019 | 43301 | 0.24 | Why? |
| Middle Aged | 42 | 2021 | 270681 | 0.23 | Why? |
| Follow-Up Studies | 10 | 2019 | 17020 | 0.23 | Why? |
| Hirudins | 2 | 2019 | 75 | 0.21 | Why? |
| Vascular Patency | 2 | 2019 | 96 | 0.21 | Why? |
| Arterio-Arterial Fistula | 1 | 2019 | 5 | 0.21 | Why? |
| Plaque, Atherosclerotic | 2 | 2017 | 423 | 0.21 | Why? |
| Atrial Fibrillation | 2 | 2017 | 2320 | 0.20 | Why? |
| Severity of Illness Index | 11 | 2018 | 48226 | 0.20 | Why? |
| Incidence | 10 | 2019 | 25622 | 0.20 | Why? |
| Mortality | 1 | 2016 | 7132 | 0.20 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2017 | 1510 | 0.19 | Why? |
| Predictive Value of Tests | 8 | 2018 | 9537 | 0.19 | Why? |
| No-Reflow Phenomenon | 1 | 2018 | 14 | 0.19 | Why? |
| Perioperative Period | 2 | 2018 | 276 | 0.19 | Why? |
| Papillary Muscles | 1 | 2017 | 8 | 0.19 | Why? |
| Blood Vessel Prosthesis | 1 | 2019 | 115 | 0.18 | Why? |
| Chordae Tendineae | 1 | 2017 | 14 | 0.18 | Why? |
| Heart Defects, Congenital | 2 | 2018 | 933 | 0.18 | Why? |
| Radiography, Interventional | 2 | 2017 | 158 | 0.18 | Why? |
| Chromium Alloys | 1 | 2017 | 10 | 0.18 | Why? |
| Ticlopidine | 2 | 2018 | 193 | 0.18 | Why? |
| Non-ST Elevated Myocardial Infarction | 2 | 2021 | 490 | 0.18 | Why? |
| Students, Medical | 1 | 2018 | 4032 | 0.18 | Why? |
| Fibrinolytic Agents | 1 | 2010 | 1702 | 0.18 | Why? |
| Sternotomy | 1 | 2018 | 45 | 0.18 | Why? |
| Ventricular Septum | 1 | 2017 | 14 | 0.18 | Why? |
| Carotid Artery, Internal | 1 | 2018 | 97 | 0.17 | Why? |
| Calcinosis | 2 | 2018 | 240 | 0.17 | Why? |
| Quality Indicators, Health Care | 3 | 2017 | 580 | 0.17 | Why? |
| Biocompatible Materials | 1 | 2019 | 214 | 0.17 | Why? |
| Diabetes Mellitus | 2 | 2017 | 8207 | 0.17 | Why? |
| Antithrombins | 2 | 2019 | 353 | 0.17 | Why? |
| Prasugrel Hydrochloride | 1 | 2018 | 114 | 0.17 | Why? |
| Expert Testimony | 2 | 2018 | 658 | 0.16 | Why? |
| Organ Size | 1 | 2018 | 384 | 0.16 | Why? |
| Computed Tomography Angiography | 2 | 2017 | 2153 | 0.16 | Why? |
| Angioplasty, Balloon | 1 | 2017 | 66 | 0.16 | Why? |
| Galectins | 1 | 2017 | 109 | 0.16 | Why? |
| Chi-Square Distribution | 2 | 2017 | 961 | 0.16 | Why? |
| Graft Occlusion, Vascular | 1 | 2017 | 105 | 0.16 | Why? |
| Aortic Valve Insufficiency | 1 | 2018 | 136 | 0.16 | Why? |
| Hyperlipidemias | 1 | 2019 | 290 | 0.16 | Why? |
| Macrolides | 1 | 2019 | 369 | 0.15 | Why? |
| Postoperative Hemorrhage | 1 | 2018 | 183 | 0.15 | Why? |
| Systole | 1 | 2017 | 252 | 0.15 | Why? |
| Thromboembolism | 2 | 2019 | 2101 | 0.15 | Why? |
| Polymers | 2 | 2017 | 507 | 0.15 | Why? |
| Coronary Occlusion | 1 | 2017 | 138 | 0.15 | Why? |
| Radial Artery | 1 | 2017 | 132 | 0.15 | Why? |
| Vasoconstriction | 1 | 2017 | 153 | 0.15 | Why? |
| Atrial Appendage | 1 | 2017 | 120 | 0.15 | Why? |
| Hypolipidemic Agents | 1 | 2018 | 208 | 0.15 | Why? |
| Proportional Hazards Models | 3 | 2017 | 6543 | 0.15 | Why? |
| Syncope | 1 | 2018 | 238 | 0.15 | Why? |
| Echocardiography, Doppler | 1 | 2017 | 269 | 0.15 | Why? |
| Vascular Calcification | 2 | 2017 | 396 | 0.15 | Why? |
| Cardiologists | 1 | 2020 | 366 | 0.15 | Why? |
| Cause of Death | 3 | 2018 | 4823 | 0.14 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.14 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.14 | Why? |
| Platelet Aggregation | 1 | 2017 | 318 | 0.14 | Why? |
| Survival Rate | 3 | 2018 | 9206 | 0.14 | Why? |
| Multimodal Imaging | 1 | 2019 | 534 | 0.14 | Why? |
| Retrospective Studies | 13 | 2021 | 105322 | 0.14 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.13 | Why? |
| Adenosine | 1 | 2018 | 509 | 0.13 | Why? |
| Societies, Scientific | 1 | 2017 | 414 | 0.13 | Why? |
| Blood Proteins | 1 | 2017 | 551 | 0.13 | Why? |
| Risk Adjustment | 1 | 2017 | 730 | 0.12 | Why? |
| Quality Assurance, Health Care | 1 | 2018 | 596 | 0.12 | Why? |
| Hospital Mortality | 5 | 2018 | 22087 | 0.12 | Why? |
| Tomography, X-Ray Computed | 3 | 2018 | 25144 | 0.12 | Why? |
| Troponin | 1 | 2019 | 1058 | 0.12 | Why? |
| Chest Pain | 1 | 2017 | 578 | 0.12 | Why? |
| Prognosis | 7 | 2018 | 32490 | 0.12 | Why? |
| Age Factors | 4 | 2019 | 21039 | 0.11 | Why? |
| Troponin T | 1 | 2017 | 771 | 0.11 | Why? |
| Multivariate Analysis | 3 | 2018 | 5440 | 0.11 | Why? |
| Dyslipidemias | 1 | 2018 | 791 | 0.11 | Why? |
| Glomerular Filtration Rate | 1 | 2017 | 1262 | 0.11 | Why? |
| Emergency Medical Services | 2 | 2018 | 3557 | 0.11 | Why? |
| Recombinant Proteins | 2 | 2019 | 3786 | 0.10 | Why? |
| Quality Improvement | 3 | 2017 | 2435 | 0.10 | Why? |
| Carotid Artery Diseases | 1 | 2013 | 251 | 0.10 | Why? |
| Comorbidity | 4 | 2018 | 34796 | 0.10 | Why? |
| Kaplan-Meier Estimate | 2 | 2017 | 4260 | 0.10 | Why? |
| Single-Blind Method | 3 | 2019 | 1283 | 0.10 | Why? |
| Endovascular Procedures | 1 | 2019 | 1302 | 0.10 | Why? |
| Hospitalization | 2 | 2019 | 54280 | 0.10 | Why? |
| Recovery of Function | 1 | 2019 | 2461 | 0.09 | Why? |
| Interdisciplinary Communication | 1 | 2017 | 1425 | 0.09 | Why? |
| Body Mass Index | 2 | 2019 | 4306 | 0.09 | Why? |
| Odds Ratio | 2 | 2018 | 5861 | 0.09 | Why? |
| Propensity Score | 1 | 2017 | 2690 | 0.09 | Why? |
| Heart Ventricles | 1 | 2017 | 1139 | 0.09 | Why? |
| Recurrence | 2 | 2017 | 3675 | 0.09 | Why? |
| Cerebrovascular Disorders | 1 | 2017 | 1040 | 0.09 | Why? |
| Troponin I | 1 | 2017 | 1298 | 0.09 | Why? |
| Anatomic Landmarks | 2 | 2017 | 44 | 0.09 | Why? |
| Frail Elderly | 1 | 2016 | 1427 | 0.08 | Why? |
| Stroke Volume | 1 | 2017 | 2153 | 0.08 | Why? |
| Adult | 13 | 2019 | 244371 | 0.08 | Why? |
| Angiography | 2 | 2018 | 301 | 0.08 | Why? |
| Blood Platelets | 1 | 2017 | 1704 | 0.08 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.08 | Why? |
| Evidence-Based Medicine | 1 | 2019 | 3228 | 0.08 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.08 | Why? |
| Risk | 1 | 2018 | 5288 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2019 | 3755 | 0.07 | Why? |
| Practice Guidelines as Topic | 3 | 2019 | 15421 | 0.07 | Why? |
| Myocardial Revascularization | 1 | 2007 | 267 | 0.07 | Why? |
| Hospitals, Community | 1 | 2010 | 475 | 0.07 | Why? |
| Healthcare Disparities | 3 | 2017 | 3893 | 0.07 | Why? |
| Patient Selection | 1 | 2019 | 4560 | 0.07 | Why? |
| Electrocardiography | 2 | 2017 | 3957 | 0.07 | Why? |
| Metabolic Syndrome | 1 | 2012 | 810 | 0.07 | Why? |
| Sex Factors | 2 | 2019 | 11014 | 0.07 | Why? |
| Shock, Cardiogenic | 1 | 2010 | 700 | 0.06 | Why? |
| Echocardiography | 1 | 2017 | 3661 | 0.06 | Why? |
| Renal Insufficiency | 1 | 2010 | 810 | 0.06 | Why? |
| Renal Insufficiency, Chronic | 1 | 2017 | 2654 | 0.06 | Why? |
| Coronary Artery Bypass | 2 | 2019 | 629 | 0.06 | Why? |
| Surveys and Questionnaires | 3 | 2020 | 43792 | 0.06 | Why? |
| Autopsy | 3 | 2018 | 3495 | 0.06 | Why? |
| Patient Safety | 1 | 2017 | 4885 | 0.06 | Why? |
| Coronary Circulation | 1 | 2003 | 188 | 0.06 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2015 | 1876 | 0.06 | Why? |
| Immunosuppressive Agents | 1 | 2019 | 6331 | 0.05 | Why? |
| Myocardial Reperfusion | 1 | 2002 | 168 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2019 | 10649 | 0.05 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.05 | Why? |
| Necrosis | 2 | 2012 | 532 | 0.05 | Why? |
| Image Interpretation, Computer-Assisted | 2 | 2018 | 665 | 0.05 | Why? |
| Adenosine Diphosphate | 1 | 2017 | 63 | 0.04 | Why? |
| Congresses as Topic | 2 | 2019 | 1347 | 0.04 | Why? |
| Masks | 1 | 2021 | 8528 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2019 | 6166 | 0.04 | Why? |
| Rosuvastatin Calcium | 1 | 2017 | 89 | 0.04 | Why? |
| Arteries | 1 | 2019 | 283 | 0.04 | Why? |
| Hyperplasia | 1 | 2017 | 204 | 0.04 | Why? |
| Platelet Function Tests | 1 | 2017 | 231 | 0.04 | Why? |
| Esophagus | 1 | 2018 | 139 | 0.04 | Why? |
| Dissection | 1 | 2017 | 164 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.04 | Why? |
| Preoperative Period | 1 | 2017 | 271 | 0.04 | Why? |
| Heart Failure | 1 | 2017 | 6638 | 0.04 | Why? |
| Quebec | 1 | 2017 | 498 | 0.04 | Why? |
| ROC Curve | 2 | 2018 | 6024 | 0.04 | Why? |
| Surgery, Computer-Assisted | 1 | 2017 | 183 | 0.04 | Why? |
| Young Adult | 4 | 2019 | 93724 | 0.04 | Why? |
| Drug Resistance | 1 | 2017 | 395 | 0.04 | Why? |
| Reference Values | 1 | 2018 | 795 | 0.04 | Why? |
| Cardiac Imaging Techniques | 1 | 2018 | 357 | 0.04 | Why? |
| Fractional Flow Reserve, Myocardial | 1 | 2017 | 173 | 0.04 | Why? |
| Analysis of Variance | 1 | 2018 | 950 | 0.03 | Why? |
| Heart Atria | 1 | 2017 | 267 | 0.03 | Why? |
| Lower Extremity | 1 | 2019 | 593 | 0.03 | Why? |
| Databases, Factual | 2 | 2020 | 6248 | 0.03 | Why? |
| Statistics, Nonparametric | 1 | 2017 | 1008 | 0.03 | Why? |
| Austria | 1 | 2017 | 1259 | 0.03 | Why? |
| Protective Factors | 1 | 2019 | 1720 | 0.03 | Why? |
| Patient Admission | 1 | 2010 | 5250 | 0.03 | Why? |
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 669 | 0.03 | Why? |
| Terminology as Topic | 1 | 2017 | 546 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2019 | 2437 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.03 | Why? |
| Angina, Unstable | 1 | 2012 | 110 | 0.03 | Why? |
| Ischemia | 1 | 2019 | 901 | 0.03 | Why? |
| Polyesters | 1 | 2011 | 94 | 0.03 | Why? |
| Drug Therapy, Combination | 2 | 2017 | 7268 | 0.03 | Why? |
| Paclitaxel | 1 | 2011 | 124 | 0.03 | Why? |
| Atherosclerosis | 1 | 2018 | 768 | 0.03 | Why? |
| Sex Distribution | 1 | 2018 | 2083 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2017 | 11304 | 0.03 | Why? |
| Tubulin Modulators | 1 | 2011 | 126 | 0.03 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.02 | Why? |
| Age Distribution | 1 | 2018 | 3567 | 0.02 | Why? |
| Chronic Disease | 1 | 2019 | 5139 | 0.02 | Why? |
| Consensus | 1 | 2019 | 6345 | 0.02 | Why? |
| Anticoagulants | 2 | 2019 | 9563 | 0.02 | Why? |
| New Zealand | 1 | 2011 | 2073 | 0.02 | Why? |
| Biomarkers | 2 | 2017 | 23361 | 0.02 | Why? |
| Referral and Consultation | 1 | 2020 | 4816 | 0.02 | Why? |
| Algorithms | 1 | 2020 | 7346 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| France | 1 | 2019 | 12074 | 0.02 | Why? |
| Myocardial Reperfusion Injury | 1 | 2003 | 129 | 0.01 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Infection Control | 2 | 2021 | 23131 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Adolescent | 2 | 2019 | 86841 | 0.01 | Why? |
| Heparin | 1 | 2011 | 2600 | 0.01 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.01 | Why? |
| Australia | 1 | 2011 | 6306 | 0.01 | Why? |
| United States | 2 | 2017 | 46150 | 0.01 | Why? |
| Microcirculation | 1 | 2002 | 447 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Treatment Failure | 1 | 2002 | 2106 | 0.01 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.01 | Why? |